Cryoport Reports Third Quarter 2026 Financial Results

The Quick Take
Third quarter revenue grew 14% year-over-year to $50.2 million Commercial Cell and Gene Therapy revenue increased 20% year-over-year Supporting a record 788 global clinical trials and 23 commercially approved cell and gene therapies as of September 30, 2026 Raises full-year 2026 revenue...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Local
FOX NEWS MEDIA'S MULTIPLATFORM COVERAGE OF 2026 MIDTERM ELECTIONS DOMINATES CABLE NEWS DELIVERING NEARLY 4.7 MILLION VIEWERS
'FOX News Democracy 26' Tops CBS News, CNN, MS NOW in Primetime, with 'Evening News' Delivering Lowest Rated Midterm Coverage of the 21st Century FOX News…
Business
Pangaea earnings beat by $0.22, revenue topped estimates
Business
Analysis-Japanese savers have rediscovered interest rates and banks are feeling it
Business
